Application of new targeted drugs in relapsed/refractory primary central nervous system lymphoma

被引：4
|
作者：
Zhou, Ying [1 ]
Xu, Xiaohong [1 ]
机构：
[1] Nantong Univ, Dept Oncol, Affiliated Tumor Hosp, Nantong, Peoples R China
来源：
HEMATOLOGY | 2022年 / 27卷 / 01期
关键词：
PCNSL; relapsed and refractory; BTK inhibitors; PI3; K; mTOR inhibitors; immunomodulators; immune checkpoint inhibitors; PRIMARY CNS LYMPHOMA; PHASE-II; LENALIDOMIDE MONOTHERAPY; IBRUTINIB MONOTHERAPY; CELL; TEMSIROLIMUS; COMBINATION; NIVOLUMAB; BLOCKADE;
D O I：
10.1080/16078454.2021.2019363
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The prognosis of patients with relapsed and refractory primary central nervous system diffuse large B cell lymphoma (PCNSL) is poor and there is no standard salvage treatment currently available. Gene expression profiling and next-generation sequencing have provided massive amounts of data, revealing the pathogenic mechanism of PCNSL and identifying potential mechanisms for therapeutic exploration. Here, we review targeted drugs that may change the current treatment model of PCNSL.
引用
收藏
页码：105 / 112
页数：8
相关论文
共 50 条
  • [41] Salvage therapy with topotecan in relapsed/refractory primary central nervous system lymphoma (PCNSL): Long-term results
    Fischer, L
    Thiel, E
    Klasen, H
    Kirchen, H
    Jahnke, K
    Pees, H
    Birkmann, J
    Korfel, A
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 125 - 125
  • [42] Selective salvage radiotherapy could provide favorable outcomes in patients with refractory or relapsed primary central nervous system lymphoma
    Kim, Nalee
    Lim, Do Hoon
    Yoon, Sang Eun
    Kim, Seok Jin
    Kim, Won Seog
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2022, 156 (02) : 307 - 316
  • [43] Orelabrutinib Combined With Lenalidomide and Immunochemotherapy for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Retrospective Analysis of Case Series
    Yang, Chuanwei
    Cui, Yong
    Ren, Xiaohui
    Li, Ming
    Yu, Kefu
    Shen, Shaoping
    Jiang, Haihui
    Li, Mingxiao
    Zhang, Xiaokang
    Zhao, Xuzhe
    Zhu, Qinghui
    Lin, Song
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [44] Long-term remissions in relapsed/refractory primary central nervous system lymphoma (PCNSL) after topotecan chemotherapy
    Fischer, L
    Thiel, E
    Klasen, HA
    Hans, K
    Jahnke, K
    Pees, H
    Birkmann, J
    Agnieszka, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 121S - 121S
  • [45] Selective salvage radiotherapy could provide favorable outcomes in patients with refractory or relapsed primary central nervous system lymphoma
    Nalee Kim
    Do Hoon Lim
    Sang Eun Yoon
    Seok Jin Kim
    Won Seog Kim
    [J]. Journal of Neuro-Oncology, 2022, 156 : 307 - 316
  • [46] Phase I clinical trial on pomalidomide and dexamethasone in treating patients with relapsed/refractory primary central nervous system lymphoma (PCNSL) or primary vitreoretinal lymphoma (PVRL).
    Tun, Han W.
    Johnston, Patrick B.
    Grommes, Christian
    Reeder, Craig B.
    Omuro, Antonio Marcilio Padula
    Menke, David M.
    Copland, John A.
    DeAngelis, Lisa Marie
    Witzig, Thomas E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] A Phase II Trial of Nivolumab and Ibrutinib for Patients with Relapsed or Refractory Central Nervous System Lymphoma
    Westin, Jason R.
    Fowler, Nathan H.
    Nastoupil, Loretta J.
    Neelapu, Sattva S.
    Lee, Hun Ju
    Hagemeister, Fredrick B.
    Rodriguez, Maria Alma
    Steiner, Raphael E.
    Ahmed, Sairah
    Parmar, Simrit
    Nair, Ranjit
    Harrison, Rebecca
    Fayad, Luis
    [J]. BLOOD, 2019, 134
  • [48] Successful Management of a Patient with Refractory Primary Central Nervous System Lymphoma by Zanubrutinib
    Cheng, Qiansong
    Wang, Jing
    Lv, Chenglan
    Xu, Jingyan
    [J]. ONCOTARGETS AND THERAPY, 2021, 14 : 3367 - 3372
  • [49] Ibrutinib in Refractory or Relapsing Primary Central Nervous System Lymphoma: A Systematic Review
    Nepal, Gaurav
    Khurana, Mahika
    Bucheli, Domenica Herrera
    Bhandari, Siddhartha
    Joshi, Utsav
    Bhagat, Riwaj
    Rehrig, Jessica Holly
    Pudasainee, Prasun
    Shing, Yow Ka
    Ortiz, Juan Fernando
    Ojha, Rajeev
    Gajurel, Bikram Prasad
    Quinonez, Jonathan
    Ruxmohan, Samir
    Albert, Trevine
    Licata, Steven
    Stien, Joel
    [J]. NEUROLOGY INTERNATIONAL, 2022, 14 (01): : 99 - 108
  • [50] Primary Central Nervous System Lymphoma
    Sinicrope, Kaylyn
    Batchelor, Tracy
    [J]. NEUROLOGIC CLINICS, 2018, 36 (03) : 517 - +
12345